Cytek Biosciences Inc (CTKB)
Operating return on assets (Operating ROA)
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating income (ttm) | US$ in thousands | -20,523 | -23,646 | -25,818 | -26,418 | -27,846 | -27,625 | -18,706 | -10,470 | -665 | 578 | 1,151 | 5,853 | 9,342 | 15,891 | 19,530 | 15,501 | 13,659 |
| Total assets | US$ in thousands | 499,500 | 491,226 | 483,725 | 492,067 | 497,669 | 519,430 | 525,054 | 524,575 | 519,476 | 499,295 | 492,817 | 485,879 | 463,700 | 454,320 | 230,279 | 224,264 | 219,979 |
| Operating ROA | -4.11% | -4.81% | -5.34% | -5.37% | -5.60% | -5.32% | -3.56% | -2.00% | -0.13% | 0.12% | 0.23% | 1.20% | 2.01% | 3.50% | 8.48% | 6.91% | 6.21% |
December 31, 2024 calculation
Operating ROA = Operating income (ttm) ÷ Total assets
= $-20,523K ÷ $499,500K
= -4.11%
Cytek Biosciences Inc's operating return on assets (operating ROA) has shown a declining trend over the periods from December 2020 to December 2024. Starting at 6.21% in December 2020, the operating ROA increased in the following quarters, peaking at 8.48% in June 2021. However, the trend then reversed with a significant decrease to 2.01% by December 2021.
The decreasing pattern continued as the operating ROA fell to negative territory by March 2023 and remained negative until December 2024. This downward trend indicates that Cytek Biosciences Inc may be facing challenges in generating operating profits relative to its assets, which could be a concern for investors and stakeholders. Further analysis would be needed to understand the underlying reasons for this downward trend and to develop strategies for improvement.
Peer comparison
Dec 31, 2024